Microangiopathy, i.e. endothelial dysfunction, has long been suggested to contribute to the development of diabetic neuropathy, although this has never been fully verified. In the present paper, we have identified the role of Hedgehog (Hh) signalling in endoneurial microvessel integrity and evaluated the impact of impaired Hh signalling in endothelial cells (ECs) on nerve function.
Introduction
Diabetic neuropathy, which results in a serious decline in patient quality of life and can lead to a number of severe complications including limb amputation and the Charcot foot, is one of the main complications of diabetes with 75% of diabetics suffering from it. Unfortunately, no treatment for neuropathy exists save keeping blood sugar within acceptable levels or treatment of symptoms. Diabetic neuropathy is classified among diabetes-associated microangiopathies; however, the contribution of neuropathy-associated microangiopathy to the development of the disease has not been fully demonstrated. Two hypotheses are proposed to explain the aetiology of diabetic neuropathy: the metabolic theory, in which neural cell function is initially impaired, and the vascular theory, in which diabetic microangiopathy is suggested to promote neuropathy. 1 Diabetes-associated nerve microangiopathies are characterized by a vessel wall thickening 2 -6 together with an increased vasoconstriction 7 leading to a deleterious decreased tissue perfusion. Accordingly, vasodilators (angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists) 8 or pro-angiogenic factors [VEGFA, Angiopoitein-1 (Angpt1)] 3, 9 have been proposed to treat peripheral neuropathy. Nevertheless, few studies have reported that more advanced stages of neuropathy-associated microangiopathy are associated with increased capillary density within the nerves, 5, 10, 11 increased endoneurial vessel permeability, 12 and inflammation, 13 suggesting that the proposed 'pro-angiogenic' strategies to treat microangiopathy in nerves might not be suitable at every stage of diabetic neuropathy. Desert Hedgehog (Dhh) belongs to the Hh family of morphogens together with Shh and Indian hedgehog (Ihh). This family of proteins was identified nearly three decades ago in drosophila as a crucial regulator of cell fate determination during embryogenesis.
14 Dhh is mainly expressed in the peripheral nerves and male gonads. 15 In peripheral nerves, Dhh is expressed by myelinating Schwann cells and has been shown to orchestrate the organization of nerve sheaths (i.e. Epi-, Peri-, and Endoneurium) by signalling to perineurial cells. In Dhh knockout mice, epineurial collagen is reduced; the perineurium is thin and disorganized and fails to express connexin 43, the basal lamina is patchy. 16 In humans, a mutation in the initiating ATG codon of Dhh, predictive of a failure of gene translation, was also associated with polyneuropathy. 17 Interestingly, Dhh expression levels were found to be reduced in the nerves of rats in which diabetes has been induced by streptozotocin. 18 Moreover, administration of Shh was shown to improve nerve function in Diabetic rats. 18, 19 Hh signalling is also well known for its effect on the vasculature. Evidence suggesting regulation of blood vessel homeostasis by Hh signalling emerged in studies of vascularization of embryonic tissues. The developing lungs of Shh-deficient mice lack proper vascularization, 20 and Ihh null mice embryos exhibit abnormal vascular invasion of cartilage. 21 Moreover, Ihh is sufficient to induce differentiation of hematopoietic and endothelial cells (ECs). 22 More recently, Hh signalling in the brain has also been shown to be necessary for blood -brain barrier integrity. 23 The role of Dhh is the least documented of the Hh morphogens. During development, Dhh has been shown to be expressed in the endothelium of large vessels. 15 In adults, the Hh pathway has been shown to be reactivated after ischaemic injury, including hind limb ischaemia (HLI) 24 and myocardial infarction. 25 Administration of Shh, as either recombinant protein or via gene therapy, has been shown to promote neovascularization of ischaemic tissues by encouraging both angiogenesis 26 and endothelial progenitor cell recruitment. 25 We found that endogenous Dhh is an essential actor of Hh-dependent ischaemia-induced angiogenesis by stimulating peripheral nerve survival and subsequent nerve-driven angiogenesis. 27 We hypothesize that the decrease in Dhh expression observed in diabetic nerve contributes to the development of neuropathy, at least in part, through its action on vasa nervorum. The objective of the present study is to characterize the specific role of Dhh in vasa nervorum homeostasis and to determine whether the loss of Dhh may contribute to the physiopathology of microangiopathy and development of neuropathy. 
Methods

Mice
Clodronate treatment
Prolonged peripheral macrophage depletion was obtained by IP injection of 100 mL Clodronate liposome suspensions (ClodronateLiposomes.com, Haarlem, The Netherlands) every 5 days for 3 weeks. Control mice received 100 mL PBS liposome suspensions. Clodronate and PBS liposomes were resuspended at room temperature before injection.
In vivo permeability assay
To quantify endoneurial capillary permeability, mice were injected with 100 mL 1% Evans blue in the tail vein, 3 h before they were sacrificed. Microscopic visualization of Evans blue extravasation was done on paraffin-embedded sciatic nerve cross-sections. Alternatively, mice were administered with 50 mL, 150 kDa, 70 kDa, or 10 FITC-Dextran (25 mg/ mL) 30 min before they were sacrificed. FITC-detxran extravasation was evaluated from whole mount sciatic nerves.
Behavioural tests
Mice were placed in individual clear acrylic box with a wire mesh floor and acclimated for 20 min. Tactile responses were evaluated by quantifying the withdrawal threshold of the hind paw in response to stimulation with flexible Von Frey filaments. The mechanical withdrawal threshold was measured by applying a series of eight calibrated Von Frey filaments (Bioseb) to the mid-plantar surface of the foot. Mice were placed in individual clear acrylic box on a glass plate and acclimated for 20 min. The hind paw withdrawal latency in response to infrared heat stimulus was determined with Plantar test (Bioseb). The baseline was set between 3 and 7 s by adjusting the heat source intensity (90 onedigit steps), and an automatic 15 s cut-off time was used to prevent tissue damage.
X-gal staining
For X-gal staining, mice were euthanized by IP injection of Pentobarbital 150 mg/kg, then perfused with LacZ fix solution (PBS containing 0.2% glutaraldehyde, 5 mmol/L EGTA, and 100 mmol/L MgCl 2 ) before sciatic nerve were harvested. Nerves were stained overnight at 378C in X-gal staining solution [1 mg/mL X-gal (Sigma)].
Immunostaining
ECs were identified with rat anti-CD31 antibodies (BD Biosciences, Le Pont de Claix, France). Smooth muscle cells were identified with mouse anti-smooth muscle a-actin (Sigma-Aldrich, Saint-Quentin Fallavier, France). GFP was identified with anti-GFP antibodies (Molecular Probes) Mannose receptor, C type 1 (Mrc-1), and VEGFA were stained using goat-anti-Mrc-1 antibodies (R&D Systems) and rabbit anti-VEGFA antibodies (Abcam), respectively. Cldn5 was identified with rabbit anti-Cldn5 antibodies (Invitrogen). For immunofluorescence analyses, primary antibodies were incubated with Alexa-Fluor-conjugated secondary antibodies (Invitrogen) and nuclei were counterstained with DAPI (1/5000). For immunohistochemical analyses, primary antibodies were sequentially stained with biotin-conjugated secondary antibodies (Vector, Laboratories) and streptavidin-horseradish peroxidase (HRP) complex (Amersham), then the stain was developed with a diaminobenzidine (DAB) substrate kit (Vector); tissues were counterstained with haematoxylin.
Quantitative RT-PCR
RNA was isolated by using Tri Reagent w (Molecular Research Center Inc.) as instructed by the manufacturer. For quantitative RT -PCR analyses, C. Chapouly et al.
total RNA was reverse transcribed with M-MLV reverse transcriptase (Promega), and amplification was performed using B-R SYBER 
Immunoprecipitation/western blot
Prior to western blot analysis, Hh proteins were immunoprecipitated with mouse anti-Hh antibodies (5E1, Developmental Studies Hybridoma Bank) while Cldn5 was immunoprecipitated with mouse anti-Cldn5 antibodies (Invitrogen) Expression of total Hh, Dhh, VEGFA, and laminin was evaluated by SDS-PAGE using rabbit anti-Hh antibodies (Santa Cruz Biotechnology), goat-anti Dhh antibodies (R&D systems) rabbit anti-VEGFA antibodies (Abcam), rabbit anti-Cldn-5 antibodies (Invitrogen), and rabbit anti-laminin antibodies (Dako), respectively. Phosphorylation of Akt was evaluated by performing SDS -PAGE with anti-Akt1 and anti-phospho-Akt (Cell signalling) antibodies. Equal protein loading was confirmed using monoclonal anti-a-tubulin antibodies (Sigma-Aldrich).
Cell culture
In vitro experiments were performed with human umbilical vein endothelial cells (HUVECs) (Promocell). HUVECs were cultured in endothelial cell growth medium-2 (EGM-2) with EGM-2 SingleQuot Kit Supplement and growth factors (Lonza).
Lentivirus/transduction
The cDNA encoding the N terminal part of Dhh (NDhh) was digested with NheI and HpaI from pIRES-NDhh 27 and cloned into a pRRLSIN.cPPT MND lentiviral plasmid (Tronolab) after NheI and PmlI digestion. Lentiviral particles were produced at the 'plateforme de vectorologie' of Bordeaux University. HUVECs were transduced via an overnight incubation in medium containing lentiviruses at a concentration yielding a MOI of 20. Successful transduction was verified by measuring GFP expression.
Statistics
Results are reported as mean + S.E.M. Comparisons between two groups were analysed for significance with the two-tailed unpaired Student's t-test (when n ¼ 3 -4) or with the Mann -Whitney test (when n ≥5) (using XLSTAT software). For comparisons between .2 groups, the KruskalWallis test, followed by a Dunn's post hoc test was made (using Anatstat software). Differences between groups were considered to be significant when P ≤ 0.05.
Results
Dhh knockdown induces sciatic nerve endoneurial vessel perturbations
We used Dhh-deficient mice (Dhh 2/2 and Dhh +/ 2 ) to investigate whether Dhh knockdown (see Supplementary material online, Figure  S1A ) is sufficient to induce microangiopathy. We first verified that Dhh +/2 and Dhh 2/2 mice develop neuropathy as suggested by developmental studies. 16 Dhh 2/2 and Dhh +/2 mice demonstrated both hypoalgesia (measured with the Plantar test) and neuropathic pain (allodynia evaluated with Von Frey filaments) which were inversely correlated with Dhh expression level (see Supplementary material online, Figure S1B and C).
The blood vessel network of Dhh-deficient nerves was examined after both in toto CD31 staining of vasa nervorum ( Figure 1A ) and CD31 staining of sciatic nerve cross-sections ( Figure 1B ). In Dhh 2/2 mice, endoneurial microvessel density was significantly increased while it did not differ significantly between WT and Dhh +/2 mice ( Figure 1C) . Furthermore, the average endoneurial lumen vessel diameter was larger in Dhh 2/2 mice compared with Dhh +/2 and WT mice ( Figure 1B and D) .
We quantified endoneurial vessel permeability by measuring Evans Blue extravasation in the sciatic nerve of Dhh-deficient mice and of their WT control littermates. Endoneurial microvessel permeability was increased in both Dhh +/ 2 and Dhh 2/ 2 mice compared with WT mice, and vessel permeability was inversely correlated with Dhh expression level ( Figure 1E and F ). These data demonstrate that Dhh deficiency is sufficient to induce endoneurial blood vessel network anomalies, including increased permeability, vasodilatation, and abnormal vessel density, demonstrating that Dhh is necessary for vasa nervorum homeostasis.
Dhh signalling to ECs is necessary to maintain BNB integrity
Because Hh ligands were shown to regulate EC function both in vitro 33, 34 and in vivo, 23 we investigated whether the vasa nervorum phenotype of Dhh-deficient mice was due to impaired Hh signalling in ECs. The direct action of Dhh on ECs was investigated using Pdgfb-Cre 
BNB permeability is associated with Cldn5 down-regulation
BNB permeability is dependent on the expression of cell-cell junction proteins including tight junction proteins Cldn5 and Occludin that have been shown to be regulated by Shh in the brain. 23 We measured the expression of Cldn5 in the sciatic nerve of Pdgfb-Cre ERT2 ;
Smo Flox/Flox and Smo Flox/Flox mice by immunostaining of nerves and immunoprecipitation assays from nerve total protein extracts. As shown in Figure 3A and B, Cldn5 expression (in green) was weaker in endoneurial vessels of Pdgfb-Cre ERT2 ; Smo flox/flox compared with control mice; Cldn5 down-regulation in the nerves of Pdgfb-Cre ERT2 ;
Smo flox/flox was confirmed by immunoprecipitation assays followed by western blot analyses ( Figure 3C and D) .
Altogether those results show that BNB permeability induced by the loss of Hh signalling in ECs is associated with Cldn5 down-regulation.
To investigate the mechanisms by which Dhh regulates Cldn5 expression, we first evaluated whether the loss of Dhh or the loss of Hh signalling in ECs affected Hh canonical signalling in the sciatic nerve. As shown in Supplementary material online, Figure S3A - Figure S3G ).
To investigate the role of the PI3K/Akt pathway in Dhh regulation of Cldn5, an in vitro approach was taken. HUVECs overexpressing Dhh were treated with GDC-0449, a Smo inhibitor, Wortmanin, a PI3K inhibitor, or vehicle. As shown in Supplementary material online, Figure  S4 , both GDC-0449 and Wortmannin decreased Cldn-5 expression in Dhh-overexpressing HUVECs demonstrating that Dhh promotes Cldn5 expression in ECs through Smo and the PI3K/Akt pathway. Contrary to differential expression of Cldn5, ZO-1 expression was not affected by Dhh overexpression.
The increased capillary density and diameter observed in Dhh
2/2 nerve is due to massive nerve inflammation Developmental studies revealed that in the absence of Dhh, the impaired development of nerve sheets is accompanied by a massive infiltration of inflammatory cells including macrophages and neutrophils. 16 We validated these results in adult mice (data not shown) and found that the macrophages infiltrating Dhh 2/2 nerves are Mrc-1+ M2 macrophages ( Figure 4A -C ) expressing VEGFA ( Figure 4D) . As a consequence, the overall VEGFA protein expression level is strongly increased in the sciatic nerve of Dhh 2/2 mice ( Figure 4E ).
The effect of macrophage infiltration on the endoneurial vascular network was evaluated after mice were depleted from macrophages by clodronate liposome or vehicle administration. As shown in Figure 4F and G, both capillary density and capillary diameter, that were specifically increased in Dhh 2/2 , returned to baseline following clodronate treatment demonstrating that these effects are not directly due to the absence of Dhh but are the consequence of nerve inflammation.
As shown in Supplementary material online, Figure S5 , Mrc-1+ macrophage infiltration and VEGFA levels were also increased in (Figures 1 and 2, respectively) . demonstrating hypoalgesia in those mice ( Figure 5A ). Moreover, Pdgfb-Cre ERT2 ; Smo flox/flox mice were more sensitive to Von Frey filaments showing that these mice experienced neuropathic pain ( Figure 5B ). These tests demonstrate, for the first time, that an EC defect is sufficient to induce neuropathy.
Impaired Hh signalling in ECs is sufficient to induce neuropathy
Dhh expression is strongly decreased in the sciatic nerves of diabetic mice
Type 2 diabetic mice (Lepr db/db ) were shown to develop diabetic neuropathy. 3 They exhibit an endoneurial vascular phenotype characterized by decreased endoneurial microvessel lumen diameter (see Supplementary material online, Figure S6A and B), an endothelium thickening Dhh promotes vasa nervorum integrity (see Supplementary material online, Figure S6C ), an increased laminin expression, representative of a basal lamina thickening (see Supplementary material online, Figure S6D and E), and an increased BNB permeability (see Supplementary material online, Figure S6F and G) but no modification in vascular density (see Supplementary material online, Figure S6H ), which is consistent with diabetic microangiopathy. 2 -6 To begin, we quantified Dhh mRNA expression in the sciatic nerves of 12-week-old Lepr db/db and in their control non-diabetic Lepr db/+ littermates. Dhh mRNA levels were down-regulated by 87 + 7% in Lepr db/db sciatic nerves ( Figure 6A ) compared with Lepr db/+ sciatic nerves. The resulting decrease in Dhh and total Hh protein expression in diabetic sciatic nerves was verified, by immunoprecipitation assays (Figure 6B -D) . To investigate mechanisms leading to the downregulation of Dhh in the setting of diabetes, we tested whether Schwann cell Dhh mRNA expression was modulated by high glucose levels, hypoxia, or advanced glycation endproducts (AGEs) and found that AGEs significantly reduced Dhh mRNA expression in primary cultured mouse Schwann cells (see Supplementary material online, Figure S7 ) strongly suggesting that the increased level of glycated proteins related to hyperglycaemia is responsible for the down-regulation of Dhh.
To demonstrate the essential role of Dhh in preserving nerve function in adult mice, Lepr db/db mice were administered with the Smoothened agonist SAG or vehicle for 7 days. Paw withdrawal latency to thermal heat of SAG-treated Lepr db/db mice was significantly reduced ( Figure 6E) . Additionally, the sensitivity of SAG-treated Lepr db/db mice to Von Frey filaments, indicative of neuropathic pain, was significantly decreased compared to PBS liposome-treated Lepr db/db mice and similar to Lepr db /+ mice ( Figure 6F ) demonstrating that the loss of Dhh expression observed in diabetic animals contributes to the development of neuropathy. These data further confirm that Dhh down-regulation is a feature of diabetic nerves in the setting of both type 2 and type 1 diabetes. 18 
Cldn5 is down-regulated in diabetic sciatic nerves
In parallel, we verified whether Dhh down-regulation in diabetic sciatic nerves was associated with a reduction in Cldn5 expression. Consistently with what we found in Pdgfb-Cre ERT2 ; Smo Flox/Flox mice, Cldn5 expression was significantly diminished in the sciatic nerves of Lepr db/db mice ( Figure 7A and B).
These results reveal, for the first time, that the increase in endoneurial capillary permeability in diabetic neuropathic nerves is associated with a Cldn5 down-regulation. Moreover, these results are fully consistent with our in vitro and in vivo data demonstrating that Dhh regulates Cldn5 expression. Furthermore, we verified that SAG therapy increases Clnd5 protein levels in the vasa nervorum of Lepr db/db mice ( Figure 7C and D) and found that Cldn5 up-regulation in SAG-treated Lepr db/db mice was associated with a significantly decreased endoneurial capillary permeability to Evans Blue ( Figure 7E and F ).
Altogether those results confirm an essential role of Hh signalling in maintenance of Cldn5 expression and endoneurial capillary integrity.
Discussion
Microangiopathy has long been suggested to be responsible for diabetic neuropathy yet, this has never been fully verified. Through utilization of endothelium-specific KO mice, the present paper demonstrates for the first time that endothelial dysfunction is sufficient to cause neuropathy. More specifically, it elucidates the crucial role of Dhh in the maintenance of BNB and its likely implication in diabetes-associated microangiopathy. First, this study confirms that Dhh expression is decreased in diabetic sciatic nerves and then demonstrates that specific inhibition of Hh signalling in ECs is sufficient to induce BNB breakdown and subsequent neuropathy. Altogether, these data identify an original mechanism, which may actively contribute to the development of diabetic neuropathy.
Recent findings from peripheral nerve injury models have revealed that exogenous Shh protein administration enhances nerve recovery. 18, 19 Addtionally, Calcutt et al. 18 found a quantitative decrease in the amount of Dhh mRNA in the sciatic nerves of streptozotocintreated rats. In accordance with these studies, we found that Dhh mRNA and protein levels are both down-regulated in Lepr db/db sciatic nerves. Dhh promotes vasa nervorum integrity Diabetic microangiopathies are characterized by a vessel wall thickening 2 -6 together with an increased vasoconstriction 7 leading to a deleterious decreased tissue perfusion. In this study, we used Dhh-deficient mice to specifically investigate the role of Dhh on vascular complications in the setting of diabetic neuropathy. As expected, basement membrane thickening, endothelium thickening, and the resulting decrease in blood vessel lumen diameter are suggested to be the direct effect of hyperglycaemia on ECs; 35, 36 however, they were not observed in Dhh-deficient mice. Conversely, this study reveals for the first time that BNB rupture is common between Lepr db/db mice and Dhh-deficient mice (Dhh +/2 and Dhh 2/2 ) suggesting that abnormal permeability observed in diabetic nerve is due to Dhh downregulation. Nerve oedema has been documented in both human and experimental diabetic neuropathy, 37 and endoneurial capillaries of human neuropathic nerves were shown to be permeable to high molecular weight molecules such as albumin; 38 results obtained in rodents, however, remain controversial. One study performed in 1978 reported that the BNB of alloxan-and streptozotocin-diabetic rat, galactose intoxicated rat, and Lepr db/db mice was impermeable to both albumin and HRP. 39 Conversely, another study has shown that extravascular albumin was markedly increased in the sciatic nerves of streptozotocindiabetic rats, the effect of which being apparent at 3 weeks of diabetes. 40 Consistent with this last study, we found extravasation of Evans blue, which is known to be mainly associated with albumin, in the sciatic nerve of Lepr db/db mice.
Few studies have reported that more advanced stages of neuropathy-associated microangiopathy were characterized by an increased capillary density 5, 10, 11 in nerves and inflammation. 13 Similarly, we found that vasodilatation and abnormal vessel density observed in the sciatic nerves of Dhh knockout mice are indirectly due to VEGFA secretion by M2 macrophage infiltration in the endoneurium (data not shown). VEGFA is a pro-angiogenic factor 41 known to be responsible for microvascular permeability 42 and to participate in retinopathy- 43 and nephropathy-associated microangiopathy. 44 Our data agreeably demonstrate that VEGFA further enhances BNB permeability induced by Dhh deficiency as well as the severity of microangiopathy in favour of the argument for a deleterious role of VEGFA in the physiopathology of diabetic neuropathy. This may explain the non-conclusive results obtained by Ropper et al. 45 with VEGF gene transfer therapy in diabetic neuropathy. The possible regulation of EC function by Hh ligands has long been controversial. In vitro, Hh ligands were shown to promote EC migration and survival and to induce capillary morphogenesis on Matrigel TM33, 34 while, in vivo, Hh signalling in ECs was shown not to be necessary for lung vasculature development. 46 Consistently, we found that Dhh does not promote ischaemia-induced angiogenesis by directly regulating EC function . 27 Recently, Alvarez et al. 23 demonstrated, for the first time, that Shh do regulate EC function in vivo by maintaining EC tight junctions in the brain. The present study demonstrates that Dhh regulates Cldn5 expression in EC and is necessary to maintain EC tight junction in the peripheral nervous system. Taken together, it appears that Hh ligands do indeed regulate EC function; nevertheless, they are not involved in the regulation of blood vessel growth, but rather in the regulation of blood vessel integrity. 
Dhh promotes vasa nervorum integrity
Hh ligands and more particularly Shh are proposed to regulate angiogenesis indirectly by promoting the expression of pro-angiogenic factors including VEGFA and Angpt1. 26, 47 Unexpectedly, we found that VEGFA levels are increased in Dhh 2/2 nerves, suggesting that Hh ligands are not necessary for VEGFA expression in the nervous system. This result is consistent with Nagase et al.'s results. 47 Additionally, our observations of VEGFA overexpression due to a massive nerve inflammation may have masked a possible slight down-regulation of innate VEGFA expression in nerve cells or fibroblasts following impaired Dhh signalling. According to previous investigations, this study shows that neuropathic pain is due to endoneurial inflammatory cytokine secretion by macrophages such as IL-1b which has been shown to strongly participate in the physiopathology of neuropathic pain. 48 Analogously, we demonstrated that clodronate liposome administration prevents neuropathic pain in streptozotocin-induced diabetic rats. 49 On the contrary, hypoalgesia is independent of inflammation as clodronate treatment of Dhh 2/2 or Pdgfb-Cre ERT2 ; Smo Flox/Flox mice did not prevent hypoalgesia (see Supplementary material online, Figure S8 ). Endoneurial oedema indeed has deleterious consequences consisting of an elevation of endoneurial hydrostatic pressure that may compromise the intrafascicular microcirculation leading to ischaemia and its accompanying pathology. Additionally, modification of the endoneurial microenvironment may be toxic for Schwann cells and/or axons. 50 Altogether our data demonstrate for the first time that Dhh signalling is necessary for vasa nervorum homeostasis in adults and that Dhh knockdown, observed in diabetic nerves, is sufficient to induce blood nerve barrier breakdown and subsequent neuropathy. Most importantly, the present work demonstrates that microangiopathy induced by Dhh knockdown is sufficient to bring about neuropathy.
In conclusion, the present study gives some clues regarding the natural history of diabetic neuropathy-associated microangiopathy in the setting of type 2 diabetes. This study demonstrates that diabetes-associated microangiopathy and more specifically abnormal BNB permeability is sufficient to induce neuropathy. With this work, we propose novel therapeutic avenues for the treatment of diabetic neuropathy through identification of new possible targets, Dhh and Cldn5, which limit endoneurial capillary permeability.
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